Feb 03, 2023

  • Corporate

Personnel Changes

TOKYO, February 3, 2023 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced the following personnel changes, effective March 30 and April 1, 2023, respectively.

[Details of Personnel Changes]
Effective March 30, 2023

Directors

NameNew ResponsibilitiesCurrent Responsibilities
Fumio Tateishi Director -
Hideo Teramoto Director -
Teresa A. Graham Director -
  • The appointment of Fumio Tateishi, Hideo Teramoto and Teresa A. Graham as Directors is subject to approval at the 112th Annual General Meeting of Shareholders, which is scheduled to be convened on March 30, 2023.
  • Masayuki Oku, Yoichiro Ichimaru and William N. Anderson are scheduled to retire from Directors as of March 30, 2023.

Audit & Supervisory Board Members

NameNew ResponsibilitiesCurrent Responsibilities
Shigehiro Yamada Audit & Supervisory Board Member (Full-time) Executive Director,
Human Resources Management Dept.
Yumiko Waseda Audit & Supervisory Board Member -
  • The appointment of Shigehiro Yamada and Yumiko Waseda as Audit & Supervisory Board Members is subject to approval at the 112th Annual General Meeting of Shareholders, which is scheduled to be convened on March 30, 2023.
  • Atsushi Sato and Yuko Maeda are scheduled to retire from Audit & Supervisory Board Members as of March 30, 2023.

Effective April 1, 2023

Director

NameNew ResponsibilitiesCurrent Responsibilities
Osamu Okuda Representative Director, President
Chief Executive Officer (CEO)
Supervisory responsibility for Corporate Planning, Partnering, External Affairs and Audit
In charge of Partnering Dept., External Affairs Dept., and Audit Dept.


Representative Director, President
Chief Executive Officer (CEO)
Supervisory responsibility for Corporate Planning, Partnering, External Affairs and Audit
In charge of Corporate Planning Dept., ASPIRE Transformation Dept., Partnering Dept., External Affairs Dept., and Audit Dept.

Vice President

NameNew ResponsibilitiesCurrent Responsibilities
Norihisa Onozawa Vice President
Head of Corporate Planning Dept.
In charge of ASPIRE Transformation Dept.
Associate Vice President
Head of Corporate Planning Dept.
  • Minoru Watanabe is scheduled to retire from Vice President as of March 31, 2023.

Please see the PDF file about other personnel changes.

Contact:

  • For Media
  • Chugai Pharmaceutical Co., Ltd.
  • Media Relations Group, Corporate Communications Dept.,
  • Toshiya Sasai
  • Tel: +81-3-3273-0881
  • E-mail: pr@chugai-pharm.co.jp
  • For Investors
  • Chugai Pharmaceutical Co., Ltd.
  • Investor Relations Group, Corporate Communications Dept.,
  • Takayuki Sakurai
  • Tel: +81-3-3273-0554
  • E-mail: ir@chugai-pharm.co.jp
  • Like
  • Post
  • LINE it!
  • E-mail
Back to top